Skip to main navigation
Fate Therapeutics, Inc.
  • About Us
    • Overview
    • Leadership
    • Corporate Responsibility
  • Pipeline
    • Overview
    • Product Candidates
      • FT819
      • FT825
      • FT836
      • FT829
      • FT522
    • Early/Expanded Access Policy
  • Science
    • Our Cells of Interest
    • iPSC Platform
    • Manufacturing
    • Publications & Presentations
  • Patients
    • Our Commitment
    • Our Therapy
    • Autoimmune Disease
    • Cancer
    • Clinical Trials
  • Collaborations
  • Careers and Culture
    • The Fate Way
    • Join Our Team
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Financials & Filings
      • SEC Filings
      • Annual Reports and Proxies
    • Corporate Governance
    • Stock Information
      • Historical Stock Lookup
    • Investors FAQs
  • Contact
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Financial & Filings
    • Corporate Governance
    • Stock Information
    • Investors FAQs

SEC Filing Details

Document Details

Form
SCHEDULE 13D/A
Filing Date
Jul 3, 2025
Document Date
Jul 3, 2025
Form Description
SCHEDULE 13D/A - Description
Filing Group
Other
Company
Fate Therapeutics, Inc.
Issuer
FATE THERAPEUTICS INC

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

Shareholder Tools

Printed Materials
Email Alerts
Download Library
RSS News Feeds
Print Page
Share
Search

  • Facebook
  • LinkedIn
  • Twitter
  • RSS

© 2026 Fate Therapeutics | 12278 Scripps Summit Drive, San Diego, CA 92131 | 866.875.1833 | LEGAL

MENU
  • About Us
    • Overview
    • Leadership
    • Corporate Responsibility
  • Pipeline
    • Overview
    • Product Candidates
      • FT819
      • FT825
      • FT836
      • FT829
      • FT522
    • Early/Expanded Access Policy
  • Science
    • Our Cells of Interest
    • iPSC Platform
    • Manufacturing
    • Publications & Presentations
  • Patients
    • Our Commitment
    • Our Therapy
    • Autoimmune Disease
    • Cancer
    • Clinical Trials
  • Collaborations
  • Careers and Culture
    • The Fate Way
    • Join Our Team
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Financials & Filings
      • SEC Filings
      • Annual Reports and Proxies
    • Corporate Governance
    • Stock Information
      • Historical Stock Lookup
    • Investors FAQs
  • Contact